Daniel L. Alkon's most recent trade in Synaptogenix Inc was a trade of 19,688 Common Stock, par value $0.0001 per share done at an average price of $1.2 . Disclosure was reported to the exchange on Dec. 16, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Synaptogenix Inc | Daniel L. Alkon | Director, President and CSO | 16 Dec 2022 | 19,688 | 35,546 | - | 1.2 | 23,072 | Common Stock, par value $0.0001 per share | |
| Synaptogenix Inc | Daniel L. Alkon | Director, See Remark | 15 Nov 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | ||
| Synaptogenix Inc | Daniel L. Alkon | Director, President and CSO | 13 Jul 2021 | 43,750 | 55,234 | - | 0 | Common Stock, par value $0.0001 per share | ||
| Synaptogenix Inc | Daniel L. Alkon | Director, Chief Scientific Officer | 14 Jun 2021 | 10,000 | 11,484 | - | 8.3 | 82,600 | Common Stock, par value $0.0001 per share |